FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072512 [Registered on: 14/08/2024] Trial Registered Prospectively
Last Modified On: 04/09/2025
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Other (Specify) [Cosmetics]  
Study Design  Single Arm Study 
Public Title of Study   Skin Lightness Activity of Silphion S-33 
Scientific Title of Study   A Pilot Study to Evaluate the skin lightness activity of Silphion S-33 on Healthy Human Subjects 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
CCFT277 Version 1.0 Dated 31 July 2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Robin Chugh 
Designation  Principal Investigator  
Affiliation  CCFT Laboratories  
Address  1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road

Meerut
UTTAR PRADESH
250002
India 
Phone  7078103723  
Fax    
Email  robinderm25@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Puneet Mittal  
Designation  Clinical Research Consultant  
Affiliation  CCFT Laboratories  
Address  1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road

Meerut
UTTAR PRADESH
250002
India 
Phone  8937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Details of Contact Person
Public Query
 
Name  Puneet Mittal  
Designation  Clinical Research Consultant  
Affiliation  CCFT Laboratories  
Address  1st Floor room 3, Skin testing lab , CCFT laboratories, AR multispecialty hospital and research center, Delhi Road


UTTAR PRADESH
250002
India 
Phone  8937015757  
Fax    
Email  puneetmittal@mgcts.org  
 
Source of Monetary or Material Support  
CCFT Laboratories, 135, Punjabipura, Delhi Road, Meerut, India 250002 
SILPHION RESEARCH PRIVATE LIMITED, 4 TH FLOOR, Old No, 95/44, First Main Road, Gandhi Nagar, Adyar, Chennai City Corporation, Chennai – 600 020. 
 
Primary Sponsor  
Name  SILPHION RESEARCH PRIVATE LIMITED, 
Address  4TH FLOOR, Old No, 95/44, First Main Road, Gandhi Nagar, Adyar, Chennai City Corporation, Chennai – 600 020. 
Type of Sponsor  Pharmaceutical industry-Indian 
 
Details of Secondary Sponsor  
Name  Address 
Not Applicable  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Robin Chugh  CCFT laboratories   AR multispecialty hospital and research center, 1st Floor room 3, Skin testing lab , CCFT laboratories, Delhi Road
Meerut
UTTAR PRADESH 
7078103723

robinderm25@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ARMHRC Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Not Applicable 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not Applicable  Not Applicable 
Intervention  Test Product- Silphion S-33  Dose: Application of test product 0.25g, over the half face at night in outward direction. Duration- once (1 day), Route of administration- Topical 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  45.00 Year(s)
Gender  Both 
Details  1. Voluntary man or women between 20 and 45 years.
2. Photo type V.
3. People with oily skin.
4. For whom the investigator considers that the compliance will be correct.
5. Cooperating, informed of the need and duration of the examinations and ready to comply with protocol procedures.
6. Having signed a Consent Form.
7. Willingness to avoid intense UV exposure on test site (sun or artificial UV) during the course of the study.
8. Willingness to avoid excessive water contact (for example swimming) or activity which causes excessive sweating (that is exercise, sauna), during the course of the study.
9. Should be able to read and write (in English, Hindi or local language).
10. Having valid proof of identity and age.  
 
ExclusionCriteria 
Details  1. Pregnant or nursing mothers
2.Scars, excessive terminal hair or tattoo on the studied area
3.Dermatological infection or pathology on the level of studied area.
4.Hypersensitivity, allergy antecedent (to any cosmetic product, raw material)
5.Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures
6.Chronic illness which may influence the outcome of the study.
7.Subjects on any medical treatment either systemic or topical which may interfere with the performance of the study treatment (presently or in the past 1 month)
8.Subject in an exclusion period or participating in another food, cosmetic or therapeutic trial. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Change in
1. Melanin Index
2. Lightening index
3. Hydration 
Day0, Day7 
 
Secondary Outcome  
Outcome  TimePoints 
Not Applicable  Not Applicable 
 
Target Sample Size   Total Sample Size="10"
Sample Size from India="10" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="0" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   24/08/2024 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="0"
Days="7" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Clinical study to evaluate the Skin Lightness Activity Of Silphion S-33 
1. Silphion S-33
The products will be tested on 10 human volunteers.
Assessment would Notice the improvement in  Melanin content, Hydration and skin Lightness with follow-up visits on Day 0, and Day 7 with Follow up measure on 8th day.

The study is done as per BIS standard 4011
 
Close